Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Solesence (SLSN) over the last 16 years, with Q3 2025 value amounting to $418000.0.

  • Solesence's Capital Expenditures fell 7020.67% to $418000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 9805.91%. This contributed to the annual value of $4.6 million for FY2024, which is 33368.22% up from last year.
  • Solesence's Capital Expenditures amounted to $418000.0 in Q3 2025, which was down 7020.67% from $546000.0 recorded in Q2 2025.
  • Solesence's Capital Expenditures' 5-year high stood at $2.6 million during Q4 2024, with a 5-year trough of $41000.0 in Q3 2023.
  • Over the past 5 years, Solesence's median Capital Expenditures value was $429000.0 (recorded in 2021), while the average stood at $631526.3.
  • In the last 5 years, Solesence's Capital Expenditures crashed by 9388.06% in 2023 and then skyrocketed by 332195.12% in 2024.
  • Solesence's Capital Expenditures (Quarter) stood at $429000.0 in 2021, then surged by 138.93% to $1.0 million in 2022, then plummeted by 80.59% to $199000.0 in 2023, then soared by 1203.02% to $2.6 million in 2024, then plummeted by 83.88% to $418000.0 in 2025.
  • Its Capital Expenditures stands at $418000.0 for Q3 2025, versus $546000.0 for Q2 2025 and $729000.0 for Q1 2025.